CCM
Consonance Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-17,875,655
| Closed | -$94.9M | – | 38 |
|
|
2019
Q3 | $94.9M | Hold |
17,875,655
| – | – | 9.39% | 2 |
|
|
2019
Q2 | $68.6M | Hold |
17,875,655
| – | – | 4.86% | 6 |
|
|
2019
Q1 | $91.2M | Buy |
17,875,655
+8,473,338
| +90% | +$43.2M | 5.75% | 7 |
|
|
2018
Q4 | $18.1M | Buy |
9,402,317
+3,357,598
| +56% | +$6.45M | 1.33% | 18 |
|
|
2018
Q3 | $22.8M | Hold |
6,044,719
| – | – | 1.23% | 26 |
|
|
2018
Q2 | $18.9M | Buy |
6,044,719
+1,050,000
| +21% | +$3.28M | 1.22% | 23 |
|
|
2018
Q1 | $11.9M | Buy |
4,994,719
+521,112
| +12% | +$1.25M | 1.09% | 21 |
|
|
2017
Q4 | $17.5M | Buy |
4,473,607
+4,104,309
| +1,111% | +$16M | 1.58% | 17 |
|
|
2017
Q3 | $931K | Buy |
+369,298
| New | +$931K | 0.1% | 19 |
|
|
2016
Q1 | – | Sell |
-2,888,942
| Closed | -$7.08M | – | 23 |
|
|
2015
Q4 | $7.08M | Sell |
2,888,942
-2,913,943
| -50% | -$7.14M | 0.95% | 14 |
|
|
2015
Q3 | $17.4M | Buy |
5,802,885
+285,000
| +5% | +$855K | 2.45% | 12 |
|
|
2015
Q2 | $22.8M | Buy |
5,517,885
+668,015
| +14% | +$2.76M | 2.29% | 14 |
|
|
2015
Q1 | $21M | Buy |
+4,849,870
| New | +$21M | 1.91% | 17 |
|